Morgan Lewis advised Phathom Pharmaceuticals Inc. in the transaction.Phathom Pharmaceuticals Inc. announced a revenue interest financing agreement for $260 million in non-dilutive capital. The agreement provides for…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
